AI in Biomedicine: Harnessing the Unicorn
The session will take place on Thursday afternoon, 26.2.26, 14:00-18:30
Artificial Intelligence is revolutionizing biomedical research—unlocking scientific breakthroughs, streamlining repetitive tasks, and challenging traditional ethical and legal frameworks. This symposium brings together global thought leaders from science, industry, and policy to explore cutting-edge AI applications in biomedicine.
What to Expect?
- Plenary talks by leading international experts
- Innovation Cup – a pitch by selected Israeli researchers
- Moderated panel on enabling early-stage, translatable AI research
Topics to Be Covered
- AI in ethics and law
- AI in pathology and image analysis
- AI in education and training
- AI in biomedical and translational research
Confirmed International Speakers
- Peter Horvath (Hungary) – AI in health
Professor Peter Horvath is a leading figure in the field of AI-driven image analysis and computational cell biology. He heads the Biological Research Centre in Szeged and leads the Synthetic and Systems Biology Unit. His research integrates deep learning and high-content screening to advance personalized medicine and drug discovery.
- Eitan Rupin (USA) – AI in pathology and biological discovery
Prof. Eitan Rupin is a computational biologist and physician-scientist at the National Institutes of Health (NIH) and the University of Maryland. His work focuses on the application of machine learning to cancer genomics, biomarker discovery, and integrative systems biology. He is widely recognized for bridging computational methods with clinical impact.
- Orly Lobel (USA) – Legal and ethical aspects of AI
Prof. Orly Lobel is a distinguished law professor and director of the Center for Employment and Labor Policy at the University of San Diego. Her work explores the intersections of AI, innovation, regulation, and ethics. A prolific author and advisor, she provides thought leadership on how law can keep pace with emerging technologies in medicine and beyond.
Innovation Cup
Selected Israeli researchers will pitch visionary ideas at the intersection of AI and biomedicine. This fast-paced competition is designed to showcase bold thinking and disruptive potential in early-stage research and innovation.
Closing Panel: From Vision to Impact
A dynamic panel of key opinion leaders selected from various disciplines will address the future of AI-powered biomedical research.
Key discussion points include:
- How can we encourage AI-driven biomedical science in Israel and globally?
- What are the common pitfalls in early-stage planning and concept development?
- What successful models or programs have managed to leapfrog the field?
- How can collaboration between biomedical research and computer science be fostered more effectively?
- What barriers exist in the Israeli innovation ecosystem—and what are its unique advantages?
Panelists will include our featured international speakers and selected local participants.